Works matching IS 11707690 AND DT 2022 AND VI 40
Results: 119
EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 123, doi. 10.1007/s40273-022-01226-7
- By:
- Publication type:
- Article
Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L.
- Published in:
- 2022
- By:
- Publication type:
- Proceeding
Estimating an EQ-5D-Y-3L Value Set for China.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 147, doi. 10.1007/s40273-022-01216-9
- By:
- Publication type:
- Article
Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 129, doi. 10.1007/s40273-022-01214-x
- By:
- Publication type:
- Article
Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 157, doi. 10.1007/s40273-022-01210-1
- By:
- Publication type:
- Article
Correction to: EQ-5D-Y Value Set for Germany.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
PharmacoEconomics: Supplement.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 121, doi. 10.1007/s40273-022-01204-z
- Publication type:
- Article
In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 181, doi. 10.1007/s40273-022-01202-1
- By:
- Publication type:
- Article
A Value Set for the EQ-5D-Y-3L in the Netherlands.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 193, doi. 10.1007/s40273-022-01192-0
- By:
- Publication type:
- Article
Value Set for the EQ-5D-Y-3L in Hungary.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 205, doi. 10.1007/s40273-022-01190-2
- By:
- Publication type:
- Article
An EQ-5D-Y-3L Value Set for Belgium.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 169, doi. 10.1007/s40273-022-01187-x
- By:
- Publication type:
- Article
EQ-5D-Y Value Set for Germany.
- Published in:
- PharmacoEconomics, 2022, v. 40, p. 217, doi. 10.1007/s40273-022-01143-9
- By:
- Publication type:
- Article
Response to Comment on "An Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1265, doi. 10.1007/s40273-022-01213-y
- By:
- Publication type:
- Article
Economic Implications of Endometriosis: A Review.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1143, doi. 10.1007/s40273-022-01211-0
- By:
- Publication type:
- Article
Comment on "An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia".
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1261, doi. 10.1007/s40273-022-01200-3
- By:
- Publication type:
- Article
Cost Effectiveness of Adding Pembrolizumab to Platinum and Fluoropyrimidine-Based Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer: A US Healthcare Payer's Perspective.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1247, doi. 10.1007/s40273-022-01196-w
- By:
- Publication type:
- Article
Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1131, doi. 10.1007/s40273-022-01195-x
- By:
- Publication type:
- Article
Conceptual Framework for Optimised Proxy Value Set Selection Through Supra-National Value Set Development for the EQ-5D Instruments.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1221, doi. 10.1007/s40273-022-01194-y
- By:
- Publication type:
- Article
Efficiency of the EmERGE Pathway of Care in Five European HIV Centres.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1207, doi. 10.1007/s40273-022-01191-1
- By:
- Publication type:
- Article
A Systematic Literature Review of the Economic Evaluations of Treatments for Patients with Chronic Myeloid Leukemia.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1159, doi. 10.1007/s40273-022-01189-9
- By:
- Publication type:
- Article
Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 12, p. 1187, doi. 10.1007/s40273-022-01182-2
- By:
- Publication type:
- Article
A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Engaging Patients and Caregivers in an Early Health Economic Evaluation: Discerning Treatment Value Based on Lived Experience.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Are We Agreed? Self- Versus Proxy-Reporting of Paediatric Health-Related Quality of Life (HRQoL) Using Generic Preference-Based Measures: A Systematic Review and Meta-Analysis.
- Published in:
- 2022
- By:
- Publication type:
- meta analysis
A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Is EQ-5D-5L Better Than EQ-5D-3L Over Time? A Head-to-Head Comparison of Responsiveness of Descriptive Systems and Value Sets from Nine Countries.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Valuing the Quality-of-Life Aged Care Consumers (QOL-ACC) Instrument for Quality Assessment and Economic Evaluation.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 10, p. 1013, doi. 10.1007/s40273-022-01186-y
- By:
- Publication type:
- Article
Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine".
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 10, p. 1011, doi. 10.1007/s40273-022-01184-0
- By:
- Publication type:
- Article
Developing an Online Infrastructure to Enhance Model Accessibility and Validation: The Peer Models Network.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Current Practices for Accounting for Preference Heterogeneity in Health-Related Discrete Choice Experiments: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Tools for the Economic Evaluation of Precision Medicine: A Scoping Review of Frameworks for Valuing Heterogeneity-Informed Decisions.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Comparison of the Content and Consistency of Methodological Quality and Transferability Checklists for Reviewing Model-Based Economic Evaluations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA.
- Published in:
- 2022
- By:
- Publication type:
- journal article
China Health Related Outcomes Measures (CHROME): Development of a New Generic Preference-Based Measure for the Chinese Population.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comment on "Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective".
- Published in:
- 2022
- By:
- Publication type:
- Letter
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Best-Worst Scaling and the Prioritization of Objects in Health: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- research
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets.
- Published in:
- 2022
- By:
- Publication type:
- research
Correction to: Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
The Opportunity of Point-of-Care Diagnostics in General Practice: Modelling the Effects on Antimicrobial Resistance.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 8, p. 823, doi. 10.1007/s40273-022-01165-3
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 8, p. 807, doi. 10.1007/s40273-022-01156-4
- By:
- Publication type:
- Article
Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 8, p. 791, doi. 10.1007/s40273-022-01152-8
- By:
- Publication type:
- Article